About: Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications. The company is headquartered in Doylestown, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.59 (-1.56%)
APRE NASDAQ Aprea Therapeutics Inc
Aprea Therapeutics Inc share price
APRE price activity
Last Price
$0.590
Change (24hr)
-0.01 USD (-1.56%)
Volume
103.45K
Volume (4w avg)
-
Open
$0.61
Day Range
$0.58 - $0.61
Previous Close
$0.60
Last Trade
12 Oct, 7:40 pm GMT+0
Delayed
12 Oct, 7:40 pm GMT+0
APRE price performance
Delayed
12 Oct, 7:40 pm GMT+0
APRE Market Signals